Abstract | INTRODUCTION: METHODS: This was a double blinded randomized controlled clinical trial. It was conducted on 84 women with random allocation in to two groups of 42 treated with mefenamic acid and vitex agnus capsules taking three times a day during menstruation for four months. Data were collected by demographic questionnaire and Higham 5 stage chart (1 month before the treatment and 4 months during the treatment)., Paired t-test, independent t-test, chi-square test, analysis of variance (ANOVA) with repeated measurements, and SPSS software were used to determine the results. RESULTS:
Mefenamic acid and vitex agnus significantly decreased bleeding. This decrease in month 4 was 52% in the mefenamic acid group and 47.6% in the vitex agnus group. The mean bleeding score changes was statistically significant between the two groups in the first three months and before the intervention. In the mefenamic acid group, the decreased bleeding was significantly more than the vitex agnus group. However, during the 4(th) month, the mean change was not statistically significant. CONCLUSION:
|
Authors | Parisa Yavarikia, Mahnaz Shahnazi, Samira Hadavand Mirzaie, Yousef Javadzadeh, Razieh Lutfi |
Journal | Journal of caring sciences
(J Caring Sci)
Vol. 2
Issue 3
Pg. 245-54
(Sep 2013)
ISSN: 2251-9920 [Print] Iran |
PMID | 25276733
(Publication Type: Journal Article)
|